Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China flag China · Delayed Price · Currency is CNY
42.15
-0.11 (-0.26%)
At close: Feb 13, 2026

SHA:603590 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
307.86189.98230.2345.25599.081,347
Short-Term Investments
129.8653.82183.820.7510.81-
Trading Asset Securities
481.36450.66396.41280.379.04181.36
Cash & Short-Term Investments
919.08694.46810.43626.36618.931,528
Cash Growth
43.54%-14.31%29.39%1.20%-59.49%-15.34%
Accounts Receivable
324.76257.38282.83296.39244.38199.48
Other Receivables
32.3733.8435.5627.736.3138.26
Receivables
357.13291.22318.39324.13250.69237.74
Inventory
59.372.3848.4736.9947.0233.94
Other Current Assets
16.1928.4852.6729.2331.198.54
Total Current Assets
1,3521,0871,2301,017947.831,808
Property, Plant & Equipment
413.86426.73414.54440.14407.06329.61
Long-Term Investments
1,0201,249984.45927.15695.95685.5
Goodwill
--97.6497.6497.6498.65
Other Intangible Assets
835.53842.67854.64812.75815.17818.21
Long-Term Deferred Tax Assets
21.4627.4732.271.098.967.05
Long-Term Deferred Charges
288.63234.36150.71120.4582.410.02
Other Long-Term Assets
117.353.3116.68.87316.338.38
Total Assets
4,0493,9203,7813,4253,3713,786
Accounts Payable
52.7673.5782.9748.4746.74108.38
Accrued Expenses
35.0145.6832.1526.8233.9935.02
Short-Term Debt
211.05140.9696.93--24.47
Current Portion of Long-Term Debt
-1.075.12---
Current Portion of Leases
9.1973.958.717.5-
Current Income Taxes Payable
19.314.690.2534.1215.848.69
Current Unearned Revenue
6.576.436.492.921.22.36
Other Current Liabilities
99.1373.2995.5351.3249.49416.11
Total Current Liabilities
433.03352.68323.39172.36154.77595.02
Long-Term Debt
55.3149.8543.78---
Long-Term Leases
4.8810.8-3.7111.12-
Long-Term Unearned Revenue
37.5840.4823.4928.9829.8335.73
Long-Term Deferred Tax Liabilities
32.6339.7227.7829.6245.0270.97
Total Liabilities
563.43493.52418.44234.68240.74701.72
Common Stock
159.36159.36160160160160
Additional Paid-In Capital
952.53944.6955.01992.46985.17971.44
Retained Earnings
2,1212,0452,0501,9311,8761,784
Treasury Stock
-19.19-35.93-78.59-124.64-124.64-
Comprehensive Income & Other
-17.131.8-26.5-32.8-8.11163.35
Total Common Equity
3,1973,1443,0602,9262,8893,078
Minority Interest
288.17281.75302.44264.22241.815.6
Shareholders' Equity
3,4853,4263,3623,1903,1313,084
Total Liabilities & Equity
4,0493,9203,7813,4253,3713,786
Total Debt
280.43209.67149.7812.4218.6224.47
Net Cash (Debt)
638.65484.79660.65613.94600.311,504
Net Cash Growth
50.95%-26.62%7.61%2.27%-60.08%-16.70%
Net Cash Per Share
4.073.104.223.933.819.43
Filing Date Shares Outstanding
159.68159.22158.98156.49156.49157.67
Total Common Shares Outstanding
159.68158.83158.98156.49156.49158.01
Working Capital
918.67733.86906.57844.35793.061,213
Book Value Per Share
20.0219.8019.2518.7018.4619.48
Tangible Book Value
2,3612,3022,1082,0161,9762,161
Tangible Book Value Per Share
14.7914.4913.2612.8812.6313.68
Buildings
-324.61322.64323.38322.3321.39
Machinery
-126.83125.74126.76114.72109
Construction In Progress
-209.85190.8181.98127.2647.7
Source: S&P Global Market Intelligence. Standard template. Financial Sources.